A Hepatic Epithelioid Hemangioendothelioma Treated by Living Donor Liver Transplantation.
- Author:
Hyung Il SEO
1
;
Sang Jae PARK
;
Seong Hoon KIM
;
Kyung Suk SUH
;
Nam Joon YI
;
Woo Jin LEE
;
Joon Il CHOI
;
Soon Ae LEE
;
Eun Kyung HONG
;
Joong Won PARK
;
Chang Min KIM
Author Information
1. Center for Liver Cancer, National Cancer Center, Korea. spark@ncc.re.kr
- Publication Type:Case Report
- Keywords:
Hepatic Epithelioid Hemangioendothelioma;
Living Donor Liver Transplantation
- MeSH:
Antigens, CD34;
Biopsy;
Cholangiocarcinoma;
Factor VIII;
Hemangioendothelioma, Epithelioid*;
Humans;
Liver Transplantation*;
Liver*;
Living Donors*;
Middle Aged;
Natural History;
Tissue Donors;
Writing
- From:Korean Journal of Hepato-Biliary-Pancreatic Surgery
2006;10(3):47-50
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Hepatic epithelioid hemangioendothelioma (HEHE) is a rare a lowgrade malignant tumor of endothelial origin. The natural history of this tumor is unpredictable and it is difficult to differentiate from cholangiocarcinoma or metastatic liver tumor on imaging study. A case of HEHE treated by living donor liver transplantation (LDLT) is presented. A 52-year-old man was admitted because of multiple bilobar liver masses. The histological appearances of the preoperative biopsy showed positive immunostaining for factor VIII and CD34 antigens. So it was dagrored as HEHE The tumor was unresectable because of multiple involvement of both lobes of the liver. The tumor was enlarged after 3months, which prompted the decision to perform LDLT. The right liver of the donor was transplanted to the recipient. The intraoperative & postoperative courses were uneventful. At the time of writing, the patient had survived for 13 months without any complications.
